Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
A randomised, double-blind, placebo-controlled trial of erythropoietin alfa versus placebo in mechanically ventilated critically ill patients following traumatic injury	KAIMRC/Australian and New Zealand Intensive Care Research Centre	Ongoing	Epoetin Alfa (Recombinant Human Erythropoietine) (EPREX)	3	EPO-TRAUMA ANZIC-RC/CF001 - CT20/046/R	King Abdulaziz Medical City NG (Riyadh)
An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial	Global Blood Therapeutics (GBT)	Ongoing	Inclacumab	3	GBT2104-133	Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants with Sickle Cell Disease and Recurrent Vaso-occlusive Crises	Global Blood Therapeutics (GBT)	Completed	Inclacumab	3	GBT2104-132	Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi
Nucala Effectiveness Study (NEST) in Emerging Markets	King Fahd University Hospital	Completed	Mepolizumab	3	213475	King Fahad University Hospital (Al-Khobar)
Prospective, Randomized, Open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine use beyond 24 horse Compared with Midazolam in children admitted to Pediatric Intensive Care unit (PICU) at KASCH-NGHA	KAIMRC	Ongoing	Dexmedetomidine	3	RC20/160/R	King Abdulaziz Medical City NG (Riyadh)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease Experiencing Vasoocclusive Crises	Global Blood Therapeutics, Inc.	Ongoing	Inclacumab	3	GBT2104-131	Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabia , Qatif Central Hospital
The Efficacy of topical Povidone – Iodine rinses in the management of CoronaVirus disease 2019 (COVID-19)	PI initiated (KSU)	Ongoing	POVIDONE IODINE	2	E-20-5656	King Khalid University Hospital (Riyadh)
Efficacy Of Single Dose Rituximab and Mycophenolate Versus Two Doses Rituximab in Children with Steroid Dependent and Frequent Relapsing Nephrotic Syndrome: Randomized Open-Labeled Pilot Trial	King Faisal Specialist Hospital and Research Center	Ongoing	Rituximab / Mycophenolate	2	2020-99	King Faisal Specialist Hospital and Research Center (Jeddah)
A Prospective Phase II study utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients with Advanced Colorectal Cancer	KAIMRC	Ongoing	PANITUMUMAB - cetuximab	2	RC20/170/R	King Abdulaziz Medical City NG (Riyadh)
Deferoxamine management protocol in COVID-19 patients	King Saud Medical City	Ongoing	Deferoxamine	2	20082103	King Saud Medical City (Riyadh)